Robert Saint-Vil, DO
Geriatric Psychiatry · Belle Mead, NJNPI 1871709642
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Indivior Inc. at 28.5% of the total. That places this record below the midpoint for geriatric psychiatry clinicians in NJ, where the typical reported total is $287.
Across 19 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$82
- Lundbeck LLC$64
- Otsuka America Pharmaceutical, Inc.$51
- Alkermes, Inc.$43
- AbbVie$34
- Neurocrine Biosciences, Inc.$13
What the payments were for
- Food & beverage$287100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 5 | $82 |
| Lundbeck LLC | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 4 | $51 |
| Alkermes, Inc. | 3 | $43 |
| AbbVie | 2 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
How this compares
$287 in reported general payments places this provider in the 50th percentile of 26 geriatric psychiatry providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $8,510 |
| RivastigmineRivastigmine Tartrate | 25 | $1,104 |
| Quetiapine Fumarate | 44 | $680 |
| Aripiprazole | 15 | $589 |
| Divalproex Sodium | 17 | $550 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $408 |
| Buspirone Hcl | 40 | $405 |
| Lamotrigine | 34 | $365 |
| Atorvastatin Calcium | 53 | $335 |
| Clonazepam | 13 | $329 |
| Metoprolol Tartrate | 14 | $317 |
| Mirtazapine | 28 | $273 |
| Trazodone Hcl | 57 | $272 |
| Levothyroxine Sodium | 26 | $234 |
| Rosuvastatin Calcium | 15 | $233 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Belle Mead
- Pritesh ShahWestwood$5K
- Lina ShihabuddinNewark$2K
- Shailaja ShahHillsborough$1K
- Gina WilberHowell$1K
- Vanajakshi PaturuFair Lawn$1K
- Sheema ImranPerth Amboy$853
- Syed RazaBrick$843
- Pooja TandonToms River$781
- Ajanta VinekarPlainsboro$631
- Marc RothmanWestmont$504
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.